The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1β interleukin-6, and vascular endothelial growth factor

Fertility and Sterility

Volumn 71, Issue 3, 1999, Pages 482-489

  Pellicer, Antonio ^a   Albert, Carmela ^a   Mercader, Amparo ^a   Bonilla Musoles, Fernando ^a   Remohí, José ^a   Simón, Carlos ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Interleukin 6; Interleukin 1 ; Ovarian hyperstimulation syndrome; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNOBLOTTING; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SYNDROME;

CHORIONIC GONADOTROPIN; ENDOTHELIAL GROWTH FACTORS; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOKINES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032915049     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00484-1     Document Type: Article

References (28)

1. Navot D., Bergh P.A., Laufer N. The ovarian hyperstimulation syndrome. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive endocrinology, surgery and technology. Vol. 2:1995;2215-2232 Lippincott-Raven, Philadelphia.
2. Balasch J., Arroyo V., Fabregues F., Salo J., Jimenez W., Pare J.C., et al. Neurohormonal and hemodynamic changes in severe cases of ovarian hyperstimulation syndrome. Ann Intern Med. 121:1994;27-33.
3. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
4. Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA. 87:1990;3092-3096.
5. Yan Z., Weich H.A., Bernat W., Beckwoldt M., Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab. 77:1993;1723-1725.
6. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H.A., et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells importance in ovarian hyperstimulation syndrome . J Clin Endocrinol Metab. 80:1995;1967-1971.
7. Gordon J.D., Mesiano S., Zaloudek C.H.J., Jaffe R.B. Vascular endothelial growth factor localization in human ovary and fallopian tubes possible role in reproductive function and ovarian cyst formation . J Clin Endocrinol Metab. 81:1996;353-359.
8. Loret de Mola J.R., Flores J.P., Baumgardner G.P., Goldfarb J.M., Gindlesperger V., Friedlander M.A. Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome ovarian immunohistochemical localization of interleukin-6 signal . Obstet Gynecol. 87:1996;581-586.
9. Abramov Y., Barak V., Nisman B., Schenker J.G. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril. 67:1997;261-265.
10. Revel A., Barak V., Lavy Y., Anteby E., Abramov Y., Schenker J.J., et al. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril. 66:1996;66-71.
11. Simón C., Tsafriri A., Pellicer A., Polan M.L. The role of interleukins in the ovary. Reprod Med Rev. 5:1996;51-63.
12. Peterson C.M., Hales H.A., Hatasaka H.H., Mitchel M.D., Rittenhouse L., Jones K.P. Interleukin-1β (IL-1β) modulates prostaglandin production and the natural IL-1 receptor antagonist inhibits ovulation in the optimally stimulated rat ovarian perfusion model. Endocrinology. 133:1993;2301-2306.
13. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., Dinarello C.A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human mononuclear cells IL-6 suppresses IL-1 and TNF . Blood. 75:1990;40-47.
14. Li J., Perrella M.A., Tsai J.C., Yet S.F., Hsieh C.M., Yoshizumi M., et al. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem. 270:1995;308-312.
15. Cohen T., Nahari D., Cerem L.W., Neufeld G. Interleukin induces the expression of vascular endothelial growth factor. J Biol Chem. 271:1996;736-741.
16. Yarali H., Fleige-Zahradka B.G., Yuen B.H., McComb P.F. The ascites in the ovarian hyperstimulation syndrome do not originate from the ovary. Fertil Steril. 59:1993;657-661.
17. Blumenfeld Z., Shabadash V., Shen-Or Z., Arnon R., Israeli E., Makler A. The origin of ascites in the ovarian hyperstimulation syndrome is mainly ovarian in humans. J Soc Gynecol Invest. 4:(Suppl):1997;123a.
18. Itskovitz-Eldor J., Kol S., Lewit N., Sealey J.E. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 82:1997;461-464.
19. Standaert F.E., Chew B.P., De Avila D., Reeves J.J. Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes. Biol Reprod. 46:1992;997-1000.
20. Toth P., Li X., Rao C.V., Lincoln S.R., Sanfilippo J.S., Spinnato J.A., et al. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab. 79:1994;307-315.
21. Goldsman M.P., Pedram A., Dominguez C.E., Ciuffardi I., Levin E., Asch R.H. Increased capillary permeability induced by human follicular fluid a hypothesis for an ovarian origin of the hyperstimulation syndrome . Fertil Steril. 63:1995;268-272.
22. McClure N., Healy D., Rogers P.A.W., Sullivan J., Beaton L., Haning R.V. Jr, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 344:1994;235-236.
23. Amato P, Zwain I, Yen SSC. Identification of vascular endothelial growth factor in human follicular fluid: a possible role in ovarian hyperstimulation syndrome. Proceedings of the 52nd Annual Meeting of the American Society for Reproductive Medicine, Birmingham, AL, 1996; Boston.
24. Neulen J, Yan Z, Wünsch E, Weich H, Breckwoldt M. Regulation of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) gene expression in human luteinized granulosa cells (GCs) in vitro. Proceedings of the 52nd Annual Meeting of the American Society for Reproductive Medicine, Birmingham, AL, 1996; Boston.
25. Loret de Mola R., Baumgardner G.P., Goldfarb J.M., Friedlander M.A. Ovarian hyperstimulation syndrome pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumor necrosis factor-a cannot predict its occurrence . Hum Reprod. 11:1996;1377-1380.
26. Ludwig M., Bauer O., Lopens A., Jelkmann W., Diedrich K. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod. 13:1998;30-32.
27. Lee A., Christenson L.K., Stouffer R.L., Burry K.A., Patton P.E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril. 68:1997;305-311.
28. Yokose S., Ishizuya T., Ikeda T., Nakamura T., Tsurukami H., Kawasaki K., et al. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats. Endocrinology. 137:1996;469-478.